Results for "mitochondrial-targeted antioxidants."
Conditions Encyclopedia Entry 1775850427
Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within muscle cells, leading to muscle weakness, fatigue, and other systemic symptoms.
Health & MedicineConditions Encyclopedia Entry 1780319348
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT** ### Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is inherited from one's mother. Mitochondrial myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms and severity of MM vary widely among individuals, making diagnosis and treatment challenging. Mitochondrial myopathies are characterized by a range of symptoms, including muscle weakness, fatigue, exercise intolerance, and muscle pain. Some individuals may also experience neurological symptoms, such as seizures, vision loss, and hearing loss. In severe cases, MM can lead to life-threatening complications, such as heart failure, respiratory failure, and kidney failure. ### History/Background The first reported case of mitochondrial myopathy was in 1962, when a British neurologist, Dr. Keith Morgan, described a patient with a rare muscle disorder. However, it wasn't until the 1980s that the genetic basis of MM was discovered. Researchers identified mutations in the mitochondrial DNA as the cause of these disorders. Since then, numerous studies have been conducted to understand the genetic and molecular mechanisms underlying MM. ### Key Information Mitochondrial myopathies are caused by mutations in the mitochondrial DNA, which is inherited from one's mother. These mutations affect the production of energy within cells, leading to a range of symptoms and complications. There are several types of MM, including: * **Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)**: A severe form of MM characterized by muscle weakness, seizures, and stroke-like episodes. * **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: A type of MM characterized by muscle weakness, seizures, and vision loss. * **Kearns-Sayre Syndrome (KSS)**: A rare form of MM characterized by muscle weakness, vision loss, and heart problems. ### Significance Mitochondrial myopathies are rare disorders, affecting approximately 1 in 5,000 people worldwide. However, they can have a significant impact on individuals and families affected by these disorders. Early diagnosis and treatment can improve the quality of life for individuals with MM, but there is currently no cure for these disorders. Research into mitochondrial myopathies has led to a greater understanding of the genetic and molecular mechanisms underlying these disorders. This knowledge has also led to the development of new treatments and therapies, such as gene therapy and mitochondrial-targeted antioxidants. **INFOBOX** - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1962 (first reported case) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting the mitochondria **TAGS:** Mitochondrial myopathies, genetic disorders, mitochondrial DNA, muscle weakness, fatigue, exercise intolerance, muscle pain, neurological symptoms, seizures, vision loss, hearing loss, heart failure, respiratory failure, kidney failure, MELAS, MERRF, KSS, gene therapy, mitochondrial-targeted antioxidants.
Health & MedicineConditions Encyclopedia Entry 1779182944
** **Mitochondrial Myopathies** are a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms. **CONTENT:** ### Overview Mitochondrial Myopathies (MM) are a diverse group of genetic disorders caused by mutations in the mitochondrial DNA, which is responsible for producing energy for the cell through the process of cellular respiration. These disorders affect the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms. Mitochondrial Myopathies are characterized by their unique inheritance pattern, as they are passed down from mother to child through the mitochondrial genome. This means that only females can pass on these disorders to their offspring, as only egg cells contribute mitochondria to the fertilized egg. Mitochondrial Myopathies can manifest in various ways, depending on the specific mutation and the affected individual. Some common symptoms include muscle weakness, particularly in the muscles of the face, arms, and legs; fatigue; exercise intolerance; and muscle pain. In some cases, patients may experience more severe symptoms, such as seizures, developmental delays, and vision loss. The progression and severity of the disorder can vary widely among individuals, and some may experience a slow decline in symptoms over time, while others may experience a rapid deterioration. ### History/Background The first reported cases of Mitochondrial Myopathies date back to the 1960s, when researchers identified a group of patients with a rare disorder characterized by muscle weakness and fatigue. Over the years, advances in genetic testing and research have led to a better understanding of the underlying causes of these disorders. In 1988, the first mitochondrial DNA mutation was identified, and since then, numerous mutations have been discovered, leading to a greater understanding of the genetic basis of Mitochondrial Myopathies. ### Key Information Mitochondrial Myopathies are caused by mutations in the mitochondrial DNA, which can be inherited from a mother or occur spontaneously. The most common mutations associated with MM include the MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes) syndrome, the MERRF (Myoclonic Epilepsy with Ragged-Red Fibers) syndrome, and the Kearns-Sayre syndrome. These disorders can be diagnosed through genetic testing, including mitochondrial DNA sequencing and muscle biopsy. ### Significance Mitochondrial Myopathies are a significant public health concern due to their rarity and the lack of effective treatments. While there is no cure for these disorders, researchers are working to develop new therapies, including gene therapy and mitochondrial-targeted antioxidants. In addition, advances in genetic testing and diagnosis have improved the ability to identify and manage these disorders, allowing patients to receive more effective care and improving their quality of life. **INFOBOX:** - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1960s (first reported cases) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting the mitochondria **TAGS:** Mitochondrial Myopathies, genetic disorders, mitochondrial DNA, muscle weakness, fatigue, exercise intolerance, muscle pain, MELAS syndrome, MERRF syndrome, Kearns-Sayre syndrome, gene therapy, mitochondrial-targeted antioxidants.
Health & MedicineConditions Encyclopedia Entry 1781417106
** Condition 1781417106, also known as **Mitochondrial Myopathies**, is a group of rare genetic disorders characterized by muscle weakness and degeneration due to impaired mitochondrial function. **CONTENT:** ### Overview Mitochondrial Myopathies are a diverse group of conditions that affect the mitochondria, the energy-producing structures within cells. Mitochondrial myopathies are caused by mutations in mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) that affect the function of the mitochondria. This impairment leads to a decrease in energy production, resulting in muscle weakness, fatigue, and other systemic symptoms. Mitochondrial myopathies can affect individuals of all ages, from infants to adults, and can be inherited in an autosomal dominant, autosomal recessive, or maternal pattern. ### History/Background The first descriptions of mitochondrial myopathies date back to the 1960s, when researchers identified a group of patients with muscle weakness and degeneration. However, it wasn't until the 1980s that the genetic basis of these conditions was understood. The discovery of mtDNA mutations in patients with mitochondrial myopathies led to a greater understanding of the role of mitochondria in energy production and the development of diagnostic tests for these conditions. Today, mitochondrial myopathies are recognized as a distinct group of disorders, with over 150 different mtDNA mutations identified. ### Key Information Mitochondrial myopathies can be classified into several subtypes, including: * **Kearns-Sayre Syndrome**: a rare condition characterized by progressive external ophthalmoplegia, muscle weakness, and cardiac conduction defects. * **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a condition characterized by myoclonic seizures, muscle weakness, and ragged-red fibers on muscle biopsy. * **NARP Syndrome**: a condition characterized by neuropathy, ataxia, and retinitis pigmentosa. * **Leigh Syndrome**: a condition characterized by progressive brain degeneration, muscle weakness, and seizures. Symptoms of mitochondrial myopathies can vary widely depending on the subtype and individual affected. Common symptoms include: * Muscle weakness and fatigue * Muscle pain and cramping * Seizures and epilepsy * Vision loss and blindness * Hearing loss and deafness * Cardiac conduction defects and arrhythmias ### Significance Mitochondrial myopathies are significant because they highlight the importance of mitochondrial function in maintaining cellular energy production. Understanding the genetic basis of these conditions has led to the development of diagnostic tests and treatments, such as gene therapy and mitochondrial-targeted antioxidants. Additionally, research on mitochondrial myopathies has shed light on the role of mitochondria in aging and age-related diseases, such as Alzheimer's and Parkinson's. **INFOBOX:** - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1960s (first descriptions) - **Location:** Worldwide - **Known For:** Impaired mitochondrial function leading to muscle weakness and degeneration **TAGS:** Mitochondrial myopathies, genetic disorders, muscle weakness, fatigue, seizures, epilepsy, vision loss, hearing loss, cardiac conduction defects, gene therapy, mitochondrial-targeted antioxidants.